![FDA Announces Voluntary Recall of Defective EpiPens](https://www.tenlaw.com/wp-content/uploads/2019/07/STANDARD-BLOG-IMAGE.jpg)
![FDA Announces Voluntary Recall of Defective EpiPens](https://www.tenlaw.com/wp-content/uploads/2019/07/STANDARD-BLOG-IMAGE.jpg)
![FDA Announces Voluntary Recall of Defective EpiPens](https://www.tenlaw.com/wp-content/uploads/2019/07/STANDARD-BLOG-IMAGE.jpg)
FDA Backs Xarelto Despite Flawed Clinical Trial
Thornton Law Firm is no longer accepting new Xarelto cases. By: Marilyn McGoldrick, Esq. Published on February 1, 2017 Recently, issues were raised concerning the results of a clinical trial for the blood thinning drug Xarelto. It was discovered that a medical device...![FDA Announces Voluntary Recall of Defective EpiPens](https://www.tenlaw.com/wp-content/uploads/2019/07/STANDARD-BLOG-IMAGE.jpg)
Thalidomide, Frances Oldham Kelsey, And The Pharmaceutical Industry
By Michael A. Lesser, Esq. Posted on Sep 25, 2013 Dr. Frances Oldham Kelsey Released in Germany in 1957 as an all-purpose sedative, but later widely used as a preventative treatment for “morning sickness,”...![FDA Announces Voluntary Recall of Defective EpiPens](https://www.tenlaw.com/wp-content/uploads/2019/07/STANDARD-BLOG-IMAGE.jpg)
DePuy ASR: First Bellwether Trial Postponed For Two Weeks
By Marilyn T. McGoldrick, Esq. Posted on Sep 9, 2013 The first DePuy ASR bellwether trial over Johnson & Johnson DePuy Unit’s hip implants, scheduled to begin today, September 9th in the consolidated federal Multi-District Litigation, has been adjourned for...![FDA Announces Voluntary Recall of Defective EpiPens](https://www.tenlaw.com/wp-content/uploads/2019/07/STANDARD-BLOG-IMAGE.jpg)